Ligand validation:6QBA

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QBA_IMD_A_202	73%	76%	0.113	0.939	0.51	0.44	-	-	0	0	100%	1
6QBA_IMD_A_204	63%	75%	0.141	0.937	0.39	0.59	-	-	0	0	100%	1
6QBA_IMD_A_203	54%	74%	0.164	0.929	0.45	0.56	-	-	0	0	100%	1
6QBA_IMD_A_206	36%	73%	0.227	0.92	0.48	0.55	-	-	0	0	100%	1
6QBA_IMD_A_205	19%	76%	0.237	0.832	0.41	0.54	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
1W8K_IMD_A_1476	99%	44%	0.042	0.978	0.79	1.36	-	1	0	0	100%	1
2ASN_IMD_X_202	99%	67%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.